A Study of Risk Factors for the Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Thyroid Function in Patients with Acute Leukemia

Jin HU; Ben NIU; Meng LI; Yanlin MA

doi:10.12259/j.issn.2095-610X.S20240707

Volume 45 Issue 7

Jul. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(7): 49-55

Jin HU, Ben NIU, Meng LI, Yanlin MA. A Study of Risk Factors for the Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Thyroid Function in Patients with Acute Leukemia[J]. Journal of Kunming Medical University, 2024, 45(7): 49-55. doi: 10.12259/j.issn.2095-610X.S20240707

Citation:

Jin HU, Ben NIU, Meng LI, Yanlin MA. A Study of Risk Factors for the Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Thyroid Function in Patients with Acute Leukemia[J]. Journal of Kunming Medical University, 2024, 45(7): 49-55. doi: 10.12259/j.issn.2095-610X.S20240707

Citation:

Jin HU, Ben NIU, Meng LI, Yanlin MA. A Study of Risk Factors for the Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Thyroid Function in Patients with Acute Leukemia[J]. Journal of Kunming Medical University, 2024, 45(7): 49-55. doi: 10.12259/j.issn.2095-610X.S20240707

PDF( 738 KB)

A Study of Risk Factors for the Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Thyroid Function in Patients with Acute Leukemia

doi: 10.12259/j.issn.2095-610X.S20240707

Jin HU¹,
Ben NIU^{1
,
,},
Meng LI¹,
Yanlin MA²

1.
Dept. of Geriatrics
2.
Dept. of Pharmacy，The Affiliated Hospital of Kunming University of Science and Technology; The 1st People’s Hospital of Yunnan Province，Kunming Yunnan 650034，China

Received Date: 2023-03-15
Available Online: 2024-06-14
Publish Date: 2024-07-25

Abstract

Abstract

Objective To investigate the incidence and identify risk factors associated with thyroid disease （TD） in patients diagnosed with acute leukemia （AL） following allogeneic hematopoietic stem cell transplantation （allo-HSCT）. Methods Clinical data of 98 AL patients who underwent allo-HSCT for the first time in the Department of Hematology of the First People's Hospital of Yunnan Province from January 2018 to June 2023 were collected and retrospectively analyzed. All AL patients were treated with anti-tumor drugs （excluding immune checkpoint inhibitors） and allo-HSCT, divided into non-TD group （n = 55） and TD group （n = 43） based on whether TD occurred. We collected the patients' general information and laboratory data, analyzed whether there were statistical differences between the two groups, and explored the related risk factors for TD after allo-HSCT treatment. Results Among the 98 AL patients who underwent allo-HSCT, 43 （43.8%） exhibited abnormal thyroid function, including 22 cases of hypothyroidism （comprising clinical and subclinical hypothyroidism）, 9 cases of hyperthyroidism （including clinical and subclinical hyperthyroidism）, and 12 cases of elevated thyroid antibodies. Univariate analysis of the non-TD group and TD group showed no statistical significance in age, gender, donor-recipient relationship, HLA matching, donor and recipient blood type, neutrophil implantation time and PLT implantation time （P > 0.05）. However, there were statistically significant differences in disease type and the presence of concurrent aGVHD （P < 0.05）. The binary logistic regression analysis revealed that aGVHD was identified as a significant risk factor for the development of thyroid disorders after transplantation （OR=3.693, 95%CI=1.166～11.699, P < 0.05）. Furthermore, when compared to the underlying disease ALL, AML and other AL exhibited a significantly higher susceptibility to thyroid disorders （P < 0.05）. Conclusion Hypothyroidism is the most common type of TD caused by allo-HSCT treatment in AL patients, and TD is more likely to occur in acute non-lymphocytic post-transplantation, and patients with aGVHD is a risk factor for TD.
- Allogeneic hematopoietic stem cell transplantation,
- Acute leukemia,
- Thyroid dysfunction

FullText(HTML)

References(31)

References

[1]	Sharma R,Jani C. Mapping incidence and mortality of leukemia and its subtypes in 21 world regions in last three decades and projections to 2030[J]. Annals of Hematology,2022,101(7):1523-1534. doi: 10.1007/s00277-022-04843-6
[2]	Zheng R,Zhang S,Zeng H,et al. Cancer incidence and mortality in China,2016[J]. Journal of the National Cancer Center,2022,2(1):1-9. doi: 10.1016/j.jncc.2022.02.002
[3]	Tang L,Huang Z,Mei H,et al. Immunotherapy in hematologic malignancies: Achievements,challenges and future prospects[J]. Signal Transduction and Targeted Therapy,2023,8(9):4043-4081. doi: 10.1038/s41392-023-01521-5
[4]	Inamoto Y,Lee S J. Late effects of blood and marrow transplantation[J]. Haematologica,2017,102(4):614-625. doi: 10.3324/haematol.2016.150250
[5]	Lawitschka A,Peters C. Long-term effects of myeloablative allogeneic hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia[J]. Current Oncology Reports,2018,20(9):1-10. doi: 10.1007/s11912-018-0719-5
[6]	中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅰ)——适应证、预处理方案及供者选择(2014年版)[J]. 中华血液学杂志,2014,35(8):775-780. doi: 10.3760/cma.j.issn.0253-2727.2014.08.029
[7]	中华医学会血液学分会干细胞应用学组. 中国异基因造血干细胞移植治疗血液系统疾病专家共识(Ⅲ)——急性移植物抗宿主病(2020年版)[J]. 中华血液学杂志,2020,41(7):529-536. doi: 10.3760/cma.j.issn.0253-2727.2020.07.001
[8]	Medinger M,Zeiter D,Heim D,et al. Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia[J]. Leukemia Research,2017,58:43-47. doi: 10.1016/j.leukres.2017.04.003
[9]	Felicetti F,Gatti F,Faraci D,et al. Impact of allogeneic stem cell transplantation on thyroid function[J]. Journal of Endocrinological Investigation,2023,46(9):1825-1834. doi: 10.1007/s40618-023-02039-x
[10]	中华医学会内分泌学分会,《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南——甲状腺疾病的实验室及辅助检查[J]. 中华内科杂志,2007,46(8):697-702.
[11]	Taylor P N,Albrecht D,Scholz A,et al. Global epidemiology of hyperthyroidism and hypothyroidism[J]. Nature Reviews. Endocrinology,2018,14(5):301-316. doi: 10.1038/nrendo.2018.18
[12]	Li Y,Teng D,Ba J,et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: Epidemiological evidence from 31 provinces of mainland China[J]. Thyroid®,2020,30(4):568-579.
[13]	Wang W,Wang S,Zhang K,et al. Hypothyroidism is associated with clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of China PEACE Study[J]. Endocrine,2021,74(1):128-137. doi: 10.1007/s12020-021-02742-w
[14]	Brenta G,Nepote A,Barreto A,et al. Low glomerular filtration rate values are associated with higher TSH in an elderly population at high cardiovascular disease risk[J]. Frontiers in Endocrinology,2023,14:1162626. doi: 10.3389/fendo.2023.1162626
[15]	张鹏程,罗琴,杨芳. 血清甲状腺激素和25-(OH)D_3对急性白血病患儿化疗疗效的影响[J]. 中国处方药,2019,17(6):164-165. doi: 10.3969/j.issn.1671-945X.2019.06.102
[16]	Paviglianiti A. Endocrine and metabolic disorders after hematopoietic cell transplantation[J]. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology,2020,37(2):111-115.
[17]	Bhatia S,Armenian S H,Landier W. How i monitor long-term and late effects after blood or marrow transplantation[J]. Blood,2017,130(11):1302-1314. doi: 10.1182/blood-2017-03-725671
[18]	Muller I,Moran C,Lecumberri B,et al. 2019 European Thyroid Association Guidelines on the management of thyroid dysfunction following immune reconstitution therapy[J]. European Thyroid Journal,2019,8(4):173-185. doi: 10.1159/000500881
[19]	Akiyama M,Inamoto K,Katayanagi N,et al. [Clinical features of thyroid dysfunction in adult Japanese after allogeneic hematopoietic stem cell transplantation][J/OL]. [Rinsho ketsueki] The Japanese journal of clinical Hematology,2022,63(8): 876-879.
[20]	Cherian K E,Kapoor N,Devasia A J,et al. Endocrine challenges and metabolic profile in recipients of allogeneic haematopoietic stem cell transplant: A cross-sectional study from Southern India[J]. Indian Journal of Hematology & Blood Transfusion,2020,36(3):484-490.
[21]	Cima L N,Martin S C,Lambrescu I M,et al. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning[J]. Journal of Pediatric Endocrinology & Metabolism: JPEM,2018,31(8): 869–878.
[22]	Zubarovskaya N,Bauer D,Ronceray L,et al. To Lighten the burden of cure: Thyroid disease in long-term survivors after TBI conditioning for paediatric ALL[J]. Frontiers in Pediatrics,2021,9:798974.
[23]	Lebbink C A,Bresters D,Tersteeg J P B,et al. Changes in thyroid function parameters 3 months after allogeneic and autologous hematopoietic stem cell transplantation in children[J]. European Journal of Endocrinology,2023,188(6):503-509. doi: 10.1093/ejendo/lvad058
[24]	Lee Y J,Lee H Y,Ahn M B,et al. Thyroid dysfunction in children with leukemia over the first year after hematopoietic stem cell transplantation[J]. Journal of Pediatric Endocrinology & Metabolism: JPEM,2018,31(11):1241-1247.
[25]	冯秋,夏宁,梁瑜祯. TH1/TH2/TH17细胞因子与造血干细胞移植术后甲状腺功能的相关性研究[J]. 重庆医学,2021,50(11):1834-1838. doi: 10.3969/j.issn.1671-8348.2021.11.008
[26]	Farhadfar N,Stan M N,Shah P,et al. Thyroid dysfunction in adult hematopoietic cell transplant survivors: Risks and outcomes[J]. Bone Marrow Transplantation,2018,53(8):977-982. doi: 10.1038/s41409-018-0109-5
[27]	Wang Y,Wu D P,Liu Q F,et al. Donor and recipient age,gender and ABO incompatibility regardless of donor source: Validated criteria for donor selection for haematopoietic transplants[J]. Leukemia,2018,32(2):492-498. doi: 10.1038/leu.2017.199
[28]	Srinivasan A,Raffa E,Wall D A,et al. Outcome of haploidentical peripheral blood allografts using post-transplantation cyclophosphamide compared to matched sibling and unrelated donor bone marrow allografts in pediatric patients with hematologic malignancies: A single-center analysis[J]. Transplantation and Cellular Therapy,2022,28(3): 158. e1-158. e9.
[29]	Ataca Atilla P,Akkus E,Atilla E,et al. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation[J]. Clinical Transplantation,2020,34(10):1-10. doi: 10.1111/ctr.14049
[30]	Milenković T,Vujić D,Vuković R,et al. Subclinical hypothyroidism in children and adolescents after hematopoietic stem cells transplantation without irradiation[J]. Vojnosanitetski Pregled,2014,71(12):1123-1127. doi: 10.2298/VSP1412123M
[31]	Pan B,Zhang Y,Sun Y,et al. Deviated balance between Th1 and Th17 cells exacerbates acute graft-versus-host disease in mice[J]. Cytokine,2014,68(2):69-75. doi: 10.1016/j.cyto.2014.04.002

Relative Articles(20)

Relative Articles

[1]	Chunyan LIU, Bingqing CHANG, Chao LI, Xin REN, Xiaoqin LIU. The Relationship between T Lymphocyte Subsets and Pathological Characteristics of Acute Myeloid Leukemia and the Value of Predicting Chemotherapy Prognosis. Journal of Kunming Medical University, 2024, 45(5): 116-122. doi: 10.12259/j.issn.2095-610X.S20240518
[2]	Qi NIE, Li LIU, Yue TIAN, Xiaoyan MAO, Qulian GUO, Xin TIAN. Abnormal Clinical Features and Prognosis of ACTH in Pediatric Acute B Lymphocytic Leukemia. Journal of Kunming Medical University, 2024, 45(10): 75-84. doi: 10.12259/j.issn.2095-610X.S20241012
[3]	Haijin LI, Huiyuan LI, Xinmiao LIU, Yue TIAN, Na LI, Zhengcheng DUAN, Xin TIAN. Clinical Features and Prognosiss of Pediatric Acute Lymphoblastic Leukemia with Hyperleukocytosis. Journal of Kunming Medical University, 2024, 45(7): 105-112. doi: 10.12259/j.issn.2095-610X.S20240716
[4]	Shulan SHI, Lijuan QIU, Liyue KUI, Min SU, Bailing ZHOU, Rongjie LI, Jianming SUN. Diagnostic Value of Interleukin-6，Interleukin-10，High-sensitivity C-reactive Protein and Procalcitonin in Children with Acute Lymphoblastic Leukemia Complicated by Infection. Journal of Kunming Medical University, 2023, 44(1): 104-108. doi: 10.12259/j.issn.2095-610X.S20230115
[5]	Yaling ZHAO, Kun WU, Rong HUANG, Genya HE, Zhenbo DING, Caiying ZHANG. Establishment and Significance of Screening System for Acute Leukemia in Children Based on Detection of TEL-AML1 Fusion Gene in Neonatal Cord Blood. Journal of Kunming Medical University, 2023, 44(1): 54-58. doi: 10.12259/j.issn.2095-610X.S20230126
[6]	YAN TANG, Bo-yi LI, Rong MA, Ling NIU, Fang LIU, Cui-juan MIAO. Correlation between Urinary Iodine and Thyroid Diseases. Journal of Kunming Medical University, 2021, 42(4): 134-137. doi: 10.12259/j.issn.2095-610X.S20210425
[7]	Ting-ting DUAN, Ya LV, Rui PAN, Li WANG, Ying TIAN. Effects of the Intensive Nursing Plan on Prevention of the Oral Mucositis Caused by Chemotherapy in Acute Leukemia. Journal of Kunming Medical University, 2021, 42(1): 167-172. doi: 10.12259/j.issn.2095-610X.S20210108
[8]	Guo Cai Ling , Wang Ling Yun . . Journal of Kunming Medical University, 2020, 41(03): 57-61.
[9]	Ma Rong , Li Bo Yi , Niu Ling , Liu Fang , Yin Li Min . . Journal of Kunming Medical University, 2020, 41(09): 72-76.
[10]	Yang Jin Rong , Ruan Jing Yan , Zeng Yun , Wu Kun , Nie Bo , Wang Xue Jiao . . Journal of Kunming Medical University, 2019, 40(09): 12-17.
[11]	Zhu Li Ping , Sun Jing . . Journal of Kunming Medical University, 2019, 40(05): 103-107.
[12]	Sun Jian Ming , He Xi Jun , Li Chang Feng , Li Hui Ying , Li Ren Qiu , Pu Ming , Su Qin . . Journal of Kunming Medical University, 2018, 39(12): 95-99.
[13]	Sun Jian Ming , Dong Fang . Adverse Reactions in Children with Acute Lymphoblastic Leukemia after Chemotherapy. Journal of Kunming Medical University, 2017, 38(10): 107-111.
[14]	Shen Xiu Fen , Xue Li , Fan Shou Rui , He Xiao Juan , Wang Xue Jiao , Yu Jing Xing , Xia Mei Hua , Yin Lie Fen . Application of Serum VEGF-C,VEGFR-2 and VEGFR-3 Expression Level in Monitoring Curative Effects and Prognosis of Acute Leukemia. Journal of Kunming Medical University, 2016, 37(11): 60-63.
[15]	Sun Jian Ming . . Journal of Kunming Medical University,
[16]	Mei Li Jun . . Journal of Kunming Medical University,
[17]	. The Fundamantal Research on RA in Treatment of Pregnant Rats with APL. Journal of Kunming Medical University,
[18]	. . Journal of Kunming Medical University,
[19]	. Analysis of Ten Sudden Death Cases of Thyroid Disease. Journal of Kunming Medical University,
[20]	Tan Lin . . Journal of Kunming Medical University,